Anti-CGRP Drug Reduces Episodic Migraine in Kids

(MedPage Today) -- SAN DIEGO -- Fremanezumab (Ajovy) cut monthly migraine days in children and adolescents with episodic migraine, according to the SPACE trial.
The phase III study showed a reduction in monthly migraine days in patients (mean...